Monogram Biosciences, Inc. - Current report filing (8-K)
2008年7月30日 - 4:50AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Earliest Event Reported: July 29, 2008
MONOGRAM BIOSCIENCES, INC.
(Exact Name of Registrant as Specified in Charter)
|
|
|
|
|
Delaware
|
|
000-30369
|
|
94-3234479
|
(State or Other Jurisdiction
of Incorporation)
|
|
(Commission File Number)
|
|
(I.R.S. Employer
Identification No.)
|
345 Oyster Point Blvd., South San Francisco, California, 94080
(Address of Principal Executive Offices, including zip code)
(650) 635-1100
(Registrants Telephone Number, including area code)
(Former Name or Former Address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
¨
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
¨
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
¨
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
¨
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Item 2.02.
|
Results of Operations and Financial Condition.
|
On July 29,
2008, Monogram Biosciences, Inc. issued a press release announcing its unaudited financial results for the quarter ended June 30, 2008. A copy of this press release is included herewith as Exhibit 99.1.
Item 9.01
|
Financial Statements And Exhibits.
|
(d) Exhibits
|
|
|
Exhibit
Number
|
|
Description
|
99.1
|
|
Press Release Issued by Monogram Biosciences, Inc. Regarding its Unaudited Financial Results, dated July 29, 2008.
|
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
|
|
|
|
|
Monogram Biosciences, Inc.
|
|
|
(Registrant)
|
|
|
|
|
|
By:
|
|
/s/ Alfred G. Merriweather
|
Date: July 29, 2008
|
|
|
|
Alfred G. Merriweather
Senior Vice President
and
Chief Financial Officer
|
INDEX TO EXHIBITS
|
|
|
Exhibit
Number
|
|
Description
|
99.1
|
|
Press Release Issued by Monogram Biosciences, Inc. Regarding its Unaudited Financial Results, dated July 29, 2008.
|
Monogram Technologies (NASDAQ:MGRM)
過去 株価チャート
から 6 2024 まで 7 2024
Monogram Technologies (NASDAQ:MGRM)
過去 株価チャート
から 7 2023 まで 7 2024